Samsung Biologics Secures $1.29 Billion Contract with U.S. Pharmaceutical Company
September 9, 2025
Seoul: Samsung Biologics Co., South Korea’s leading biotech firm, announced that it has secured a 1.8 trillion-won (US$1.29 billion) contract to provide manufacturing services for